Elif Ertürk

8PUBLICATIONS
22CO-AUTHORS
Molecular targetsMedical biochemistry - proteins and peptides (incl. medical proteomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 15, 2026
Promoter Methylation and Somatic Mutations in Cancer-Related Genes Are Associated with Hyperprogressive Disease in Patients with Malignant Melanoma and Renal Cell Carcinoma Receiving Anti-PD-1/PD-L1 Immunotherapy.

|Jul 12, 2025
A New Treatment Strategy for Lung Cancer With HDAC and Wnt/β-Catenin Pathway Inhibitors.

Elif Erturk, Oguzhan Akgun, Yaren Yildiz

|May 14, 2025
Resveratrol modulates triosephosphate isomerase and mineralization in osteosarcoma cells: potential target for novel therapeutic strategies.

Gonca Tuna, Sibel Çinar Asa, Elif Ertürk

|Oct 22, 2024
Correction: Value of miR-31 and mir-150-3p as diagnostic and prognostic biomarkers for breast cancer.

Elif Erturk, Ferda Ari, Omer Enes Onur

|Oct 01, 2024
Value of miR-31 and miR-150-3p as diagnostic and prognostic biomarkers for breast cancer.

Elif Erturk, Ferda Ari, Omer Enes Onur

|Dec 28, 2023
Soloxolone methyl induces apoptosis and oxidative/ER stress in breast cancer cells and target cancer stem cell population.

Elif Ertürk, Oğuzhan Akgün, Yaren Yildiz

Pageof 2

Frequent Collaborators

7 joint publications

Ferda Ari

4 joint publications

Oğuzhan Akgün

3 joint publications

Omer Enes Onur

3 joint publications

Yaren Yildiz